[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Murray, 1967 - Google Patents

A comparative study of the effect of selected oral hypoglycemic agents on protein biosynthesis

Murray, 1967

View PDF
Document ID
5202944555427258323
Author
Murray H
Publication year

External Links

Snippet

The atudy at proteina and at their metabolic pathways haa been very extensive due to the tact that they are second only to nucleic acids in importance in the formation and well-being of an organism. Beside. making up most at the non-ake1etal structure of an organism# …
Continue reading at ecommons.luc.edu (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Frimpter Cystathioninuria: nature of the defect
EP0057942A2 (en) Cysteine delivery system
JP3859699B2 (en) Therapeutic composition
Bourne Biochemistry and physiology of nutrition
CS195254B2 (en) Method of producing tri-p-toluensulphonate s-adenosyl-l-methionine
Thomson 9 Alcohol and nutrition
Touster Pentose metabolism and pentosuria
Windebank Neurotoxicity of pyridoxine analogs is related to coenzyme structure
Riordan et al. The effects of a primary nutritional deficiency (Vitamin B study)
Evans et al. The activity of the pyrimidine biosynthetic pathway in MGH-U1 transitional carcinoma cells grown in tissue culture
IL258487B2 (en) Compositions and methods for treatment of homocystinuria
Stibbs et al. Further studies on the metabolism of tryptophan in Trypanosoma brucei gambiense: Cofactors, inhibitors, and end-products
Murray A comparative study of the effect of selected oral hypoglycemic agents on protein biosynthesis
Shah Morphological, Cellular, and Biochemical Aspects of Differentiation of Normal Hamster and Teratogen-Treated Palate in and Chick Embryos
WO1999001125A1 (en) A pharmaceutical composition containing kynurenine and thymine or tryptophan and thymine
EP0838220A1 (en) Drug for ameliorating brain diseases
Lin et al. Role of enzymatic adaptation in production of experimental alkaptonuria.
Dounce et al. Attempted enzymatic phosphorylation of ribonucleic acid
Wigler et al. Cytotoxic nucleotide analogs as potential anticancer agents. 5-Bromodeoxyuridine 5'-methylphosphonate
WO2004093877A1 (en) Vitamin comprising pyroloquinoline quinone and use thereof
Oxenkrug et al. Ontogenetic effects of MAO‐A inhibition on rat pineal n‐acetylserotonin and melatonin during the first month of neonatal life
EP1475090A1 (en) Drugs for mitochondrial diseases
Runner Changing syntheses in development
Pratt Biochemical studies in mice an inherited, progressive muscular dystrophy
CN117599091A (en) Application of bezoar in preparing medicine for preventing or treating hyperuricemia